.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Fish and Richardson
McKinsey
Colorcon
Farmers Insurance
Accenture
Argus Health
Johnson and Johnson
QuintilesIMS
Cipla

Generated: September 25, 2017

DrugPatentWatch Database Preview

ORLAAM Drug Profile

« Back to Dashboard

Which patents cover Orlaam, and when can generic versions of Orlaam launch?

Orlaam is a drug marketed by Roxane and is included in one NDA.

The generic ingredient in ORLAAM is levomethadyl acetate hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levomethadyl acetate hydrochloride profile page.

Summary for Tradename: ORLAAM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list7
Clinical Trials: see list1
Patent Applications: see list261
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORLAAM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
ORLAAM
levomethadyl acetate hydrochloride
CONCENTRATE;ORAL020315-001Jul 9, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Department of Justice
Mallinckrodt
Harvard Business School
Teva
Boehringer Ingelheim
Dow
Cantor Fitzgerald
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot